Simulation Study for the Lead Time in Cancer Screening When Human Lifetime Is a Competing Risk.

doi 10.18297/etd/736
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University of Louisville

Related search

Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: Is It Time?

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

A Simulation Approach to Determine the Probability of Demand During Lead-Time When Demand Distributed Normal and Lead-Time Distributed Gamma

Journal of Economics and Behavioral Studies
2014English

Competing for Space: Factors That Lead to Sponge Overgrowth When Interacting With Octocoral

Open Journal of Marine Science
2015English

High‐risk Human Papillomavirus Test a Good Option for Cervical Cancer Screening

Cancer
Cancer ResearchOncology
2018English

Colorectal Cancer Screening: The Time to Act Is Now

BMC Medicine
Medicine
2015English

Overdiagnosis in Mammographic Screening Because of Competing Risk of Death

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer?

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

A Simulation Study of the Effect of Screening on Lung Cancer Mortality in Asia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Reporting of Adjuvant Breast Cancer Trials: When Is the Right Time?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy